Daniel (Dan) Soland (Uniqure N.V. (Nasdaq: QURE))

Soland, Daniel (Dan) (Uniqure 201512–201609 CEO before ViroPharma + Chiron Vaccines + Epigenesis RESIGNED 9/16)

	Organisation	Uniqure N.V. (Nasdaq: QURE)
	Former/major organisation	ViroPharma Inc. (Nasdaq: VPHM)
	Today	Shire (Group)
	Product	gene therapy
	Product 2	pharmaceutical

Record changed: 2017-04-09

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)